ESC Professional Premium Access

Cardio-oncology – Cancer treatment and cardiovascular toxicity

Event: ESC Congress 2022
Topic: Cardio-Oncology
Session type: Clinical Cases
Date: 27 August 2022
Time: 15:30 - 16:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Cardio-oncology – Cancer treatment and cardiovascular toxicity - Get ready for the session.

Thumbnail

Cardiotoxicity evaluation in a patient with recidivant breast cancer and rheumatic heart disease.

Speaker: Doctor A. Issa (Rio de Janeiro, BR)
Thumbnail

CAR-T cell induced takotsubo syndrome: a case report.

Speaker: Associate Professor F. Guerra (Ancona, IT)
Thumbnail

Multimodality imaging approach in a vascular toxicity case caused by cabozantinib.

Speaker: Doctor G. Benetos (Athens, GR)
Thumbnail

Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.

Speaker: Doctor T. Nagai (Omihachiman, JP)
Thumbnail

4 speakers from this session

Doctor Aurora Issa

National Institute of Cardiology, Rio de Janeiro (Brazil)
1 presentation
0 follower

Associate Professor Federico Guerra

Marche Polytechnic University of Ancona, Ancona (Italy)
4 presentations
0 follower

Doctor Georgios Benetos

University of Athens Medical School, Athens (Greece)
1 presentation
0 follower

Doctor Tomoyuki Nagai

Omihachiman community medical center, Omihachiman (Japan)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk